Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001873128 | SCV002138613 | uncertain significance | not provided | 2021-08-05 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. This variant has not been reported in the literature in individuals affected with RMND1-related conditions. This variant is present in population databases (rs377114459, ExAC 0.02%). This sequence change replaces arginine with glutamine at codon 23 of the RMND1 protein (p.Arg23Gln). The arginine residue is weakly conserved and there is a small physicochemical difference between arginine and glutamine. |
Fulgent Genetics, |
RCV002506932 | SCV002816420 | uncertain significance | Combined oxidative phosphorylation defect type 11 | 2022-04-22 | criteria provided, single submitter | clinical testing |